|
|
||||||||
1 Department of Laboratory Medicine, Oita Medical University, Oita 879-5593, Japan; and 2 Department of Pharmacology, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan
| |
ABSTRACT |
|---|
|
|
|---|
Although mitochondrial ATP-sensitive
potassium (mitoKATP) channels have been reported to reduce
the extent of apoptosis, the critical timing of
mitoKATP channel opening required to protect myocytes
against apoptosis remains unclear. In the present study, we
examined whether the mitoKATP channel serves as a trigger
of cardioprotection against apoptosis induced by oxidative
stress. Apoptosis of cultured neonatal rat cardiomyocytes was
determined by flow cytometry (light scatter and propidium
iodide/annexin V-FITC fluorescence) and by nuclear staining with
Hoechst 33342. Mitochondrial membrane potential (
) was measured
by flow cytometry of cells stained with rhodamine-123 (Rh-123).
Exposure to H2O2 (500 µM) induced
apoptosis, and the percentage of apoptotic cells increased
progressively and peaked at 2 h. This
H2O2-induced apoptosis was associated
with the loss of 
, and the time course of decrease in Rh-123
fluorescence paralleled that of apoptosis. Pretreatment of
cardiomyocytes with diazoxide (100 µM), a putative
mitoKATP channel opener, for 30 min before exposure to
H2O2 elicited transient and mild depolarization
of 
and consequently suppressed both apoptosis and 
loss after 2-h exposure to H2O2. These
protective effects of diazoxide were abrogated by the
mitoKATP channel blocker 5-hydroxydecanoate (500 µM)
but not by the sarcolemmal KATP channel blocker HMR-1098
(30 µM). Our results suggest for the first time that
diazoxide-induced opening of mitoKATP channels triggers
cardioprotection against apoptosis induced by oxidative stress
in rat cardiomyocytes.
cardiomyocytes; mitochondria; mitochondrial membrane potential; preconditioning
| |
INTRODUCTION |
|---|
|
|
|---|
ISCHEMIC PRECONDITIONING (IPC) is a phenomenon in which brief episodes of conditioning ischemia can blunt subsequent lethal injury of the heart (23). This endogenous cardioprotective mechanism has been conceptually divided into triggers and mediators/effectors (3). Mitochondrial ATP-sensitive potassium (mitoKATP) channels have been proposed to be the viable end-effectors of IPC (8, 18, 29). A recent study by Pain et al. (27) further proposed that mitoKATP channels serve as triggers rather than end-effectors via the generation of reactive oxygen species (ROS). Thus the mitoKATP channel appears to play dual roles, both as a trigger and a mediator/effector of cardioprotection (11, 17, 24). Although the definition of IPC was initially used to describe a reduction in myocardial necrosis, it has been reported that IPC reduces ischemic injury by decreasing apoptosis (6, 9, 20, 28, 36). Recently, Akao et al. (1) demonstrated that diazoxide, a putative mitoKATP channel opener, inhibited apoptosis induced by exposure to H2O2 for 16 h. They used cultured neonatal rat ventricular myocytes and applied diazoxide simultaneously with H2O2, suggesting that the mitoKATP channel acts as a mediator/effector of cardioprotection against apoptosis. However, it remains unclear whether antiapoptotic effects can be triggered by opening of mitoKATP channels. The present study was designed to investigate the critical timing of mitoKATP channel opening required to confer antiapoptotic effects, and it demonstrates for the first time that opening of mitoKATP channels by diazoxide acts as a trigger of cardioprotection against apoptosis.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Preparation of cultured neonatal rat cardiomyocytes. The experimental protocol was approved in advance by the Ethics Review Committee for Animal Experimentation of Oita Medical University. Neonatal cardiomyocytes were prepared from 3- to 5-day-old Wistar rats as described previously (35). Cardiomyocytes were then plated onto 30-mm culture dishes at a density of 5 × 106 per dish and cultured in DMEM supplemented with 5% fetal bovine serum at 37°C under 5% CO2. On day 4, cardiomyocytes beating synchronously were used for experiments.
Assessment of apoptosis and mitochondrial membrane
potential by flow cytometry.
Flow cytometric analysis was performed with an EPICS (Beckman Coulter
Instruments) on a minimum of 1 × 104 unfixed cells
per sample. Cardiomyocytes were trypsinized with trypsin-EDTA,
resuspended in PBS, and loaded with 10 µM propidium iodide (PI; Wako
Pure Chemical Industries, Osaka, Japan) and 1 µM annexin V-FITC
(Immunotech, Marseille, France) at 4°C for 10 min. In separate
experiments, before being resuspended by trypsinization, cardiomyocytes
were incubated with 10 µM rhodamine-123 (Rh-123; Molecular Probes,
Eugene, OR) at 37°C for 10 min and then loaded with PI at room
temperature for 5 min. Apoptosis was identified as cells with
low forward scatter (FSC) on side scatter (SSC)/FSC dot plots, PI dim
staining on FSC/PI dot plots, and annexin V-positive and PI-negative
staining on annexin V/PI dot plots (5, 14, 19). The mean
fluorescence intensity of Rh-123 on the histograms measured by flow
cytometry was used to determine the loss of mitochondrial membrane
potential (
). Fluorescence probes were excited with an air-cooled
488-nm argon laser. The emission fluorescence was monitored at 525 nm
for Rh-123 or annexin V-FITC and 620 nm for PI. Data were analyzed with
the Coulter software package (Phoenix Flow).
Analysis of apoptotic nuclei by fluorescent microscopy. To detect the characteristic features of apoptotic nuclei, unfixed cardiomyocytes were stained with 0.12 µM Hoechst 33342 (Wako), a fluorescent DNA-binding dye, for 10 min. Fluorescence of Hoechst 33342 (excited at 365 nm and emitted at 400 nm) was captured with a charge-coupled device camera under a fluorescent microscope. Apoptotic cells were identified by their typical morphological appearance, with chromatin condensation and nuclear fragmentation. An average of >500 nuclei from random fields was analyzed for each data point.
Determination of lactate dehydrogenase in culture medium. Lactate dehydrogenase (LDH) released to the culture medium was determined with an LDH assay kit (Eiken Chemical, Tokyo, Japan). Approximately 5 × 106 cardiomyocytes were placed into 35-mm culture dishes containing 1 ml of culture medium (DMEM supplemented with 5% fetal bovine serum). After 2-h exposure to H2O2, 500 µl of supernatant was carefully collected for LDH determination.
Experimental protocols.
The experimental protocols are depicted in Fig.
1. Apoptosis was induced by
exposing cardiomyocytes to 500 µM H2O2.
The dose of H2O2 was chosen on the basis of
previous reports that the induction of apoptosis in neonatal
rat cardiomyocytes occurred via activation of the mitochondrial
apoptotic pathway (4, 32). To investigate the role of
the mitoKATP channel as a trigger of cardioprotection against H2O2-induced apoptosis,
cardiomyocytes were pretreated with diazoxide for 30 min and then
washed twice with PBS before incubation with
H2O2 for 2 h. In the control group,
cardiomyocytes obtained from sister cultures received vehicle only
without exposure to H2O2. In the
H2O2 group, cardiomyocytes were incubated with H2O2 alone. In the
H2O2+DZ(P) group, cardiomyocytes were
pretreated with 100 µM diazoxide (Sigma, St. Louis, MO) for 30 min
before H2O2 incubation. In the
H2O2+DZ(P)+5-HD(P) group, cardiomyocytes were
pretreated with diazoxide and 500 µM 5-hydroxydecanoate (5-HD; Sigma)
before H2O2 incubation. In the
H2O2+DZ(P)+5-HD(C) group, cardiomyocytes were
pretreated with diazoxide before H2O2
incubation and 5-HD was coadministered with
H2O2. In the
H2O2+DZ(P)+ HMR(P) group, cardiomyocytes were
pretreated with diazoxide and 30 µM HMR-1098 (kindly provided by
Aventis Pharma) before H2O2 incubation.
|
Statistical analysis. Data are expressed as means ± SE. Differences between groups were examined for statistical significance by ANOVA with Fisher's post hoc test. A P value <0.05 denoted the presence of a statistically significant difference.
| |
RESULTS |
|---|
|
|
|---|
H2O2 induces apoptosis of
cardiomyocytes.
Figure 2A shows the
representative flow cytometric analysis of cardiomyocytes stained with
PI and annexin V-FITC. Side and forward scatter (SSC/FSC) dot plots
identified two distinct cell subpopulations, and cells with high FSC
signals (R1) were predominant in controls. Exposure to
H2O2 for 2 h shifted the cells into the lower portion of the diagram (R2). When cell subpopulations were detected on FSC/PI dot plots, apoptotic cells in the dim PI
fluorescence region (R4) increased after exposure to
H2O2. Moreover, annexin V-positive and
PI-negative apoptotic cells (R9) were prominent after exposure to
H2O2. Figure 2A further shows the
nuclear morphology of cardiomyocytes stained with Hoechst 33342. The
apoptotic features of chromatin condensation and nuclear
fragmentation were observed after 2-h exposure to
H2O2. As summarized in Fig. 2B, the
percentage of apoptotic cells in the low-FSC subpopulation (R2) was
significantly increased from 18 ± 1% in the control sister
culture to 45 ± 2% after exposure to
H2O2 (n = 5; P < 0.01). Similarly, H2O2 significantly increased the degree of apoptosis assessed by PI staining
(36 ± 2% vs. 16 ± 2%, n = 5;
P < 0.01), annexin V-PI double staining (40 ± 2% vs. 19 ± 1%, n = 5; P < 0.01), and Hoechst 33342 staining (35 ± 4% vs. 7 ± 1%,
n = 11; P < 0.01). These results
indicate that H2O2 induced apoptosis of
rat neonatal cardiomyocytes and that the degree of apoptosis
determined by four different methods was comparable.
|
Time course of H2O2-induced
apoptosis and 
loss.
Figure 3 shows the time courses of
apoptotic cell death and 
loss during exposure to
H2O2. Here, apoptotic cells were identified as the low-FSC subpopulation and 
loss was assessed by relative change in the mean fluorescence intensity of Rh-123. The percentage of
apoptotic cell death increased progressively and peaked at 2 h
(285 ± 78% of control sister culture, n = 8;
P < 0.01). The time course of decrease in Rh-123
fluorescence paralleled that of apoptotic cell death, and 
after 2-h exposure to H2O2 decreased to 53 ± 10% (n = 8; P < 0.01) of the
control sister culture. These results suggest that
H2O2-induced apoptosis was associated
with loss of 
.
|
Diazoxide prevents H2O2-induced
apoptosis and 
loss.
We then examined whether pretreatment with diazoxide attenuated
H2O2-induced apoptosis and 
loss.
As shown in Fig. 4,
H2O2-induced apoptotic cells in the low-FSC
subpopulation accompanied the dissipation of 
, which was evident
by the leftward shift in Rh-123 fluorescence. The mean intensity of
Rh-123 fluorescence measured on the histogram was 40.0 in the sister
control culture and 12.4 after H2O2 incubation for 2 h. Pretreatment with diazoxide for 30 min attenuated both apoptotic cell death and 
loss induced by exposure to
H2O2, and the mean intensity of Rh-123
fluorescence was restored to 24.7. Summarized data shown in Fig.
5 confirm that the results in Fig. 4 are
indeed representative. H2O2 significantly
increased apoptotic cell death to 338 ± 41% of the control
sister culture (n = 15; P < 0.01) and
decreased the 
assessed by mean intensity of Rh-123 fluorescence
to 56 ± 8% of control (n = 15; P < 0.01). Diazoxide pretreatment [H2O2+DZ(P)
group] significantly attenuated apoptotic cell death to 228 ± 19% of control (n = 15; P < 0.01 vs. H2O2 group) and restored the loss of 
to 78 ± 8% of control (n = 15; P < 0.01 vs. H2O2 group). The selective
mitoKATP channel blocker 5-HD (30) applied
together with diazoxide [H2O2+DZ(P)+5-HD(P) group] prevented the effects of diazoxide, and the extent of
apoptotic cell death and loss of 
was similar to that induced
by H2O2 alone. In contrast, when 5-HD was
coadministered with H2O2 after the application
of diazoxide [H2O2+DZ(P)+5-HD(C) group], the
drug failed to inhibit the effect of diazoxide. These effects of 5-HD suggest that opening of the mitoKATP channel by diazoxide
indeed acts as a trigger of cardioprotection against
H2O2-induced apoptosis. Moreover,
HMR-1098, a selective sarcolemmal KATP channel blocker (31), applied together with diazoxide before
H2O2
[H2O2+DZ(P)+HMR(P) group], did not affect the
protective effects of diazoxide, suggesting that the sarcolemmal
KATP channel is not involved in the antiapoptotic effect of diazoxide.
|
|
Diazoxide prevents H2O2-induced necrosis. H2O2 induced not only apoptosis but also necrosis. The level of LDH in the culture medium was significantly increased from 0.059 ± 0.013 IU/ml (n = 6) in the control sister culture to 0.278 ± 0.015 IU/ml after 2-h exposure to H2O2 (n = 6; P < 0.001). Pretreatment with diazoxide for 30 min significantly reduced the LDH level to 0.222 ± 0.014 IU/ml (n = 6; P < 0.05 vs. H2O2 group). When necrotic cell death was assessed as a percentage of the bright PI fluorescence region (R3), H2O2 increased necrosis from 4.7 ± 0.5% (n = 6) in control to 9.3 ± 1.3% (n = 6; P < 0.01) after H2O2 exposure. Pretreatment with diazoxide again attenuated necrotic cell death to 5.6 ± 0.3% (n = 6; P < 0.01 vs. H2O2 group).
Transient depolarization of 
triggers cardioprotection.
We investigated the effect of diazoxide on 
during the triggering
period (Fig. 6). Diazoxide significantly
depolarized the 
and decreased the intensity of Rh-123
fluorescence to 74 ± 5% of the control sister culture
(n = 5; P < 0.01) after a 15-min application. This depolarization of 
restored to 87 ± 4%
of control (n = 5; P = not significant)
after 30 min. Transient depolarization of 
observed after a
15-min application of diazoxide was abolished by 5-HD (88 ± 6%,
n = 5). Thus the 
measured just before
application of H2O2 was comparable among the
groups. Nevertheless, diazoxide prevented the loss of 
induced by
subsequent exposure to H2O2 for 2 h. These
results suggest that the transient depolarization of 
during the
triggering period might contribute to the mechanism of
cardioprotection.
|
| |
DISCUSSION |
|---|
|
|
|---|
The major findings of the present study were that 1)
pretreatment of rat cardiomyocytes with diazoxide, a putative
mitoKATP channel opener, elicited the transient
depolarization and attenuated the subsequent apoptotic cell death
and 
loss induced by exposure to H2O2;
and 2) these effects of diazoxide were antagonized by the
mitoKATP channel blocker 5-HD but not by the sarcolemmal
KATP channel blocker HMR-1098. Our data therefore suggest
that mitoKATP channels serve as a trigger of
cardioprotection against apoptosis induced by oxidative stress.
H2O2 has been reported to induce
apoptosis of cardiomyocytes through activation of the
mitochondrial apoptotic pathway (4, 32), where loss of

is a key step associated with cytochrome c release
from the mitochondria (10). Our results confirmed that
this was indeed the case, and H2O2 induced the
apoptosis of cultured neonatal rat cardiomyocytes, determined
by flow cytometric analysis (light scatter, PI, and annexin V-FITC
staining) and by nuclear morphology (Hoechst 33342 staining).
Furthermore, consistent with a previous report (4),
H2O2-induced apoptosis was associated with the loss of 
as shown by Rh-123 fluorescence. Besides
apoptosis, we also found that H2O2
increased necrotic cells, which is in agreement with a previous study
in neonatal mouse cardiomyocytes (33). LDH release
increased by approximately fivefold, whereas PI-positive cells
increased by approximately twofold after exposure to
H2O2. A probable reason for this is that
necrotic cells become nonadherent and hence may be removed when the
cell layer is washed and resuspended in PBS for flow cytometric
analysis. The degree of necrotic cells assessed as a percentage of the
bright PI fluorescence region (~9%) was substantially smaller than
that of apoptotic cells (~40%). Accordingly, cultured neonatal
rat cardiomyocytes predominantly showed apoptotic cell death after
exposure to H2O2 under our experimental conditions.
Although the mitoKATP channel was initially proposed to be
the end-effector of IPC (8, 18, 29), the triggering action of mitoKATP channels has also been proposed using infarct
size as the end point. Pain et al. (27) showed that 5-HD
administered early to bracket preconditioning ischemia could
abolish the infarct size-limiting effect of IPC. Baines et al.
(2) demonstrated that diazoxide administered before
ischemia but not after the onset of index ischemia
reduced infarct size. The results presented here confirm that
pretreatment with diazoxide acts as a trigger, thereby attenuating the
necrotic cell death induced by H2O2. Recently, in addition to reduction of infarct size, IPC has been reported to
reduce apoptosis (6, 9, 20, 28, 36). Akao et al. (1) reported that diazoxide attenuated both apoptotic
cell death and 
loss induced by exposure to
H2O2 for 16 h, and these effects of
diazoxide were antagonized by 5-HD. Because diazoxide and/or 5-HD were
applied together with H2O2 in their study, the results support the idea that mitoKATP channel acts as a
mediator/effector of cardioprotection against apoptosis. A
novel and interesting finding in the present study is that
apoptotic cell death and 
loss after 2-h exposure to
H2O2 were significantly attenuated when
diazoxide was applied for 30 min before exposure to
H2O2. We confirmed that this indeed resulted
from opening of mitoKATP channels: 5-HD, but not HMR-1098,
completely abolished the antiapoptotic effects of diazoxide (Fig.
5). Moreover, once cardiomyocytes were pretreated with diazoxide,
subsequent application of 5-HD together with
H2O2 could not block the protection afforded by
diazoxide. Together, these results indicate that the
mitoKATP channel acts as a trigger of cardioprotection
against apoptosis. We further found that the triggering action
of diazoxide to reduce apoptotic cell death could not be observed
after 16-h exposure to H2O2 (data not shown).
Thus the mitoKATP channel apparently triggers an early phase of protection that lasts for ~2 h.
The precise mechanism by which diazoxide prevents apoptosis
remains unclear. It has been reported that diazoxide-induced opening of
mitoKATP channels causes mild depolarization of 
,
thereby attenuating mitochondrial Ca2+ overload induced by
ouabain and metabolic inhibition (13, 22). Mitochondrial
Ca2+ overload results in the opening of permeability
transition pore (PTP), which in turn causes the loss of 
and
release of cytochrome c (10). Therefore,
prevention of PTP by attenuating mitochondrial Ca2+
overload may be a critical mechanism of cardioprotection. Indeed, Akao
et al. (1) demonstrated that diazoxide inhibited the
cytochrome c release and loss of 
induced by
H2O2. Recently, Minners et al.
(21) reported that pharmacological preconditioning by
diazoxide uncoupled mitochondria and decreased 
in Girardi cells
and C2C12 myotubes. In the present study, we
also found that diazoxide depolarized the 
during triggering
period (Fig. 6). However, it should be noted that depolarization of

induced by diazoxide was transient and that there was no
significant depolarization of 
just before application of
H2O2. This finding implies that prevention of
mitochondrial Ca2+ overload in association with 
cannot account for the triggering mechanism of cardioprotection.
Alternatively, ROS generation is thought to be a trigger of signaling
pathways mediating IPC. Pain et al. (27) demonstrated that
the triggering effect of diazoxide was lost when a scavenger of ROS was
coadministered with diazoxide. Forbes et al. (7) provided
direct evidence that diazoxide increases ROS production. Therefore, it
has been hypothesized that opening of mitoKATP channels by
diazoxide may lead to ROS generation. ROS may then activate downstream
PKC. Okamura et al. (25) reported that the protective
effect of IPC against apoptosis was blocked by a PKC inhibitor.
Liu et al. (16) further demonstrated that PKC-
is
involved in inhibition of apoptosis by IPC. Moreover, Wang and
Ashraf (34) demonstrated diazoxide-induced PKC
translocation in Langendorff-perfused rat hearts and showed that these
effects could be blocked by PKC inhibitors. Thus such a PKC-dependent mechanism mediated by ROS generation might contribute to the
antiapoptotic effect of diazoxide. In a preliminary experiment,
however, we observed that a ROS scavenger only partially inhibited the
transient depolarization of 
during application of diazoxide and
could not completely abolish the antiapoptotic effect of diazoxide. Regarding the infarct size-limiting effects, ROS seems to be involved in the triggering action of mitoKATP channels. However, it
remains unclear whether the ROS-dependent mechanism may be involved in the antiapoptotic effect of mitoKATP channels.
In conclusion, the results of our study provide novel evidence that
opening of mitoKATP channels by diazoxide acts as a trigger and reduces apoptotic cell death. Although we used
H2O2 to induce apoptosis, it will be
interesting to see whether mitoKATP channels trigger
antiapoptotic effects in an in vivo setting. More recently, it has
been proposed that diazoxide inhibits respiratory chain, which may
serve as a predictive mechanism for ROS generation (12). However, this idea is contrary to a study demonstrating that diazoxide can suppress ROS generation and reduce cytochrome c release
at reoxygenation in a potassium-independent manner (26).
Furthermore, although diazoxide has been shown to depolarize 
, a
modest depolarization of 
would be expected to decrease ROS
generation rather than increase it (15). Obviously, how
diazoxide might be linked to ROS generation remains unclear. Further
studies are required to define the mechanism by which diazoxide sets
the heart into a preconditioned state against apoptosis.
| |
ACKNOWLEDGEMENTS |
|---|
This study was supported by a grant from the Ministry of Education, Science, Sports and Culture of Japan (H. Yonemochi and T. Sato) and the Mitsui Life Social Welfare Foundation (T. Sato).
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: H. Yonemochi, Dept. of Laboratory Medicine, Oita Medical Univ., 1-1 Idaigaoka, Hasama, Oita 879-5593, Japan (E-mail: yonemo{at}oita-med.ac.jp).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
First published March 6, 2003;10.1152/ajpheart.01073.2002
Received 16 December 2002; accepted in final form 25 February 2003.
| |
REFERENCES |
|---|
|
|
|---|
1.
Akao, M,
Ohler A,
O'Rourke B,
and
Marban E.
Mitochondrial ATP-sensitive potassium channels inhibit apoptosis induced by oxidative stress in cardiac cells.
Circ Res
88:
1267-1275,
2001
2.
Baines, CP,
Liu GS,
Birincioglu M,
Critz SD,
Cohen MV,
and
Downey JM.
Ischemic preconditioning depends on interaction between mitochondrial KATP channels and actin cytoskeleton.
Am J Physiol Heart Circ Physiol
276:
H1361-H1368,
1999
3.
Cohen, MV,
Baines CP,
and
Downey JM.
Ischemic preconditioning: from adenosine receptor to KATP channel.
Annu Rev Physiol
62:
79-109,
2000[Web of Science][Medline].
4.
Cook, SA,
Sugden PH,
and
Clerk A.
Regulation of Bcl-2 family proteins during development and in response to oxidative stress in cardiac myocytes: association with changes in mitochondrial membrane potential.
Circ Res
85:
940-949,
1999
5.
Darzynkiewicz, Z,
Bruno S,
Del Bino G,
Gorczyca W,
Hotz MA,
Lassota P,
and
Traganos F.
Features of apoptotic cells measured by flow cytometry.
Cytometry
13:
795-808,
1992[Web of Science][Medline].
6.
Fliss, H,
and
Gattinger D.
Apoptosis in ischemic and reperfused rat myocardium.
Circ Res
79:
949-956,
1996
7.
Forbes, RA,
Steenbergen C,
and
Murphy E.
Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism.
Circ Res
88:
802-807,
2001
8.
Garlid, KD,
Paucek P,
Yarov-Yarovoy V,
Murray HN,
Darbenzio RB,
D'Alonzo AJ,
Long NJ,
Smith MA,
and
Grover GJ.
Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels: possible mechanism of cardioprotection.
Circ Res
81:
1072-1082,
1997
9.
Gottlieb, RA,
Gruol DL,
Zhu JY,
and
Engler RL.
Preconditioning in rabbit cardiomyocytes: role of pH, vacuolar proton ATPase, and apoptosis.
J Clin Invest
97:
2391-2398,
1996[Web of Science][Medline].
10.
Green, DR,
and
Reed JC.
Mitochondria and apoptosis.
Science
281:
1309-1312,
1998
11.
Gross, GJ,
and
Fryer RM.
Mitochondrial KATP channels: triggers or distal effectors of ischemic or pharmacological preconditioning?
Circ Res
87:
431-433,
2000
12.
Hanley, PJ,
Mickel M,
Löffler M,
Brandt U,
and
Daut J.
KATP channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart.
J Physiol
542:
735-741,
2002
13.
Ishida, H,
Hirota Y,
Genka C,
Nakazawa H,
Nakaya H,
and
Sato T.
Opening of mitochondrial KATP channels attenuates the ouabain-induced calcium overload in mitochondria.
Circ Res
89:
856-858,
2001
14.
Karwatowska-Prokopczuk, E,
Nordberg JA,
Li HL,
Engler RL,
and
Gottlieb RA.
Effect of vacuolar proton ATPase on pHi, Ca2+, and apoptosis in neonatal cardiomyocytes during metabolic inhibition/recovery.
Circ Res
82:
1139-1144,
1998
15.
Korshunov, SS,
Skulachev VP,
and
Starkov AA.
High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria.
FEBS Lett
416:
15-18,
1997[Web of Science][Medline].
16.
Liu, H,
Zhang HY,
Zhu X,
Shao Z,
and
Yao Z.
Preconditioning blocks cardiocyte apoptosis: role of KATP channels and PKC-
.
Am J Physiol Heart Circ Physiol
282:
H1380-H1386,
2002
17.
Liu, Y,
and
O'Rourke B.
Opening of mitochondrial KATP channels triggers cardioprotection: are reactive oxygen species involved?
Circ Res
88:
759-752,
2001.
18.
Liu, Y,
Sato T,
O'Rourke B,
and
Marban E.
Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection?
Circulation
97:
2463-2469,
1998
19.
Martin, SJ,
Reutelingsperger CP,
McGahon AJ,
Rader JA,
Van Schie RC,
LaFace DM,
and
Green DR.
Early redistribution of plasma membrane phosphatidylserine is a general future of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Sb1.
J Exp Med
182:
1545-1577,
1995
20.
Maulik, N,
Yoshida T,
Engelman RM,
Deaton D,
Flack JE, III,
Rousou JA,
and
Das DK.
Ischemic preconditioning attenuates apoptotic cell death associated with ischemia/reperfusion.
Mol Cell Biochem
186:
139-145,
1998[Web of Science][Medline].
21.
Minners, J,
Lacerda L,
McCarthy J,
Meiring JJ,
Yellon DM,
and
Sack MN.
Ischemic and pharmacological preconditioning in Girardi cells and C2C12 myotubes induce mitochondrial uncoupling.
Circ Res
89:
787-792,
2001
22.
Murata, M,
Akao M,
O'Rourke B,
and
Marban E.
Mitochondrial ATP-sensitive potassium channels attenuate matrix Ca2+ overload during simulated ischemia and reperfusion: possible mechanism of cardioprotection.
Circ Res
89:
891-898,
2001
23.
Murry, CE,
Jennings RB,
and
Reimer KA.
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.
Circulation
74:
1124-1136,
1986
24.
Oldenburg, O,
Cohen MV,
Yellon DM,
and
Downey JM.
Mitochondrial KATP channels: role in cardioprotection.
Cardiovasc Res
55:
429-437,
2002
25.
Okamura, T,
Miura T,
Iwamoto H,
Shirakawa K,
Kawamura S,
Ikeda Y,
Iwatate M,
and
Matsuzaki M.
Ischemic preconditioning attenuates apoptosis through protein kinase C in rat hearts.
Am J Physiol Heart Circ Physiol
277:
H1997-H2001,
1999
26.
Ozcan, C,
Bienengraeber M,
Dzeja PP,
and
Terzic A.
Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygenation.
Am J Physiol Heart Circ Physiol
282:
H531-H539,
2002
27.
Pain, T,
Yang XM,
Critz SD,
Yue Y,
Nakano A,
Liu GS,
Heusch G,
Cohen MV,
and
Downey JM.
Opening of mitochondrial KATP channels triggers the preconditioned state by generating free radicals.
Circ Res
87:
431-433,
2000
28.
Piot, CA,
Padmanaban D,
Ursell PC,
Sievers RE,
and
Wolfe CL.
Ischemic preconditioning decreases apoptosis in rat heart in vivo.
Circulation
96:
1598-1604,
1997
29.
Sato, T,
and
Marban E.
The role of mitochondrial KATP channels in cardioprotection.
Basic Res Cardiol
95:
285-289,
2000[Web of Science][Medline].
30.
Sato, T,
O'Rourke B,
and
Marban E.
Modulation of mitochondrial ATP-dependent K+ channels by protein kinase C.
Circ Res
83:
110-114,
1998
31.
Sato, T,
Sasaki N,
Seharaseyon J,
O'Rourke B,
and
Marban E.
Selective pharmacological agents implicate mitochondrial but not sarcolemmal KATP channels in ischemic cardioprotection.
Circulation
101:
2418-2423,
2000
32.
Von Harsldorf, R,
Li PF,
and
Diet R.
Signaling pathways in reactive oxygen species-induced cardiomyocytes apoptosis.
Circulation
99:
2934-2941,
1999
33.
Wang, GW,
Schuschke DA,
and
Kang YJ.
Metallothionein-overexpressing neonatal mouse cardiomyocytes are resistant to H2O2 toxicity.
Am J Physiol Heart Circ Physiol
276:
H167-H175,
1999
34.
Wang, Y,
and
Ashraf M.
Role of protein kinase C in mitochondrial KATP channel-mediated protect ion against Ca2+ overload injury in rat myocardium.
Circ Res
84:
1156-1165,
1999
35.
Yonemochi, H,
Yasunaga S,
Teshima Y,
Takahashi N,
Nakagawa M,
Ito M,
and
Saikawa T.
Rapid electrical stimulation of contraction reduces the density of
-adrenergic receptors and responsiveness of cultured neonatal rat cardiomyocytes: possible involvement of microtubule disassembly secondary to mechanical stress.
Circulation
101:
2625-2630,
2000
36.
Zhao, ZQ,
and
Vinten-Johansen J.
Myocardial apoptosis and ischemic preconditioning.
Cardiovasc Res
55:
438-455,
2002
This article has been cited by other articles:
![]() |
Z. Sun, X. Zhang, K. Ito, Y. Li, R. A. Montgomery, S. Tachibana, and G. M. Williams Amelioration of oxidative mitochondrial DNA damage and deletion after renal ischemic injury by the KATP channel opener diazoxide Am J Physiol Renal Physiol, March 1, 2008; 294(3): F491 - F498. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Marinovic, M. Ljubkovic, A. Stadnicka, Z. J. Bosnjak, and M. Bienengraeber Role of sarcolemmal ATP-sensitive potassium channel in oxidative stress-induced apoptosis: mitochondrial connection Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1317 - H1325. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Roseborough, D. Gao, L. Chen, M. A. Trush, S. Zhou, G. M. Williams, and C. Wei The Mitochondrial K-ATP Channel Opener, Diazoxide, Prevents Ischemia-Reperfusion Injury in the Rabbit Spinal Cord Am. J. Pathol., May 1, 2006; 168(5): 1443 - 1451. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. V. Cuong, N. Kim, J. B. Youm, H. Joo, M. Warda, J.-W. Lee, W. S. Park, T. Kim, S. Kang, H. Kim, et al. Nitric oxide-cGMP-protein kinase G signaling pathway induces anoxic preconditioning through activation of ATP-sensitive K+ channels in rat hearts Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1808 - H1817. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shinmura, K. Tamaki, T. Sato, H. Ishida, and R. Bolli Prostacyclin attenuates oxidative damage of myocytes by opening mitochondrial ATP-sensitive K+ channels via the EP3 receptor Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2093 - H2101. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sarre, N. Lange, P. Kucera, and E. Raddatz mitoKATP channel activation in the postanoxic developing heart protects E-C coupling via NO-, ROS-, and PKC-dependent pathways Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1611 - H1619. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |